Search Results - "Aft R"

Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment.

Authors: Sun H Cao S Mashl RJ et al.

Corporate Authors: Sun H Cao S Mashl RJ et al.

Source: Nature communications [Nat Commun] 2022 Jan 07; Vol. 13 (1), pp. 294. Date of Electronic Publication: 2022 Jan 07.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE

Subsequent primary cancer incidence among cancer survivors in the United States, 1975–2019: An age–period–cohort analysis.

Authors: Cheng, Hui G. Aduse-Poku, Livingstone McGill, Chelsey et al.

Source: PLoS Medicine. 4/28/2026, Vol. 23 Issue 4, p1-15. 15p.

Age and tumor size as independent predictors of malignancy in BI-RADS 4 and 5 breast lesions: A cross-sectional study in Vietnam.

Authors: Nguyen, De Van Pham, Trung Van Dinh, Tam Huu et al.

Source: PLoS ONE. 7/6/2026, Vol. 21 Issue 7, p1-10. 10p.

Evaluating the Association of Ki-67 with Oncotype DX Recurrence Score in Early-Stage ER-Positive/HER2-Negative Breast Cancer.

Authors: Dragoumis, Dimitrios Kapetsis, George Louis, Konstantinos et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1731. 19p.

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.

Authors: Kong T Mabry A Highkin M et al.

Source: Nature communications [Nat Commun] 2026 Jan 27; Vol. 17 (1), pp. 949. Date of Electronic Publication: 2026 Jan 27.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Postmastectomy radiotherapy in pN1 breast cancer: Survival outcomes and prognostic factors from a single-institution cohort.

Authors: Narasimhan, Raksha M. Saini, Aren Singh Samimi, Kayla et al.

Source: PLoS ONE. 6/1/2026, Vol. 21 Issue 6, p1-15. 15p.

Multidisciplinary Management of Malignant Phyllodes Tumours of the Breast: A Case-Based Illustration and Systematic Review.

Authors: Di Stefano, Greta Marino, Graziella Thodas, Alexios et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 10, p4376. 18p.

A Rare Presentation of Palpable Bilateral Male Breast Cancer: A Case Report.

Authors: Malof, Morgan McMillan, Alexandra Torres, Flor Jasmin et al.

Source: Case Reports in Oncology. May2026, Vol. 19 Issue 1, p896-903. 8p. 3 Illustrations.

Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial.

Authors: Zhang, Jian Meng, Yanchun Wang, Biyun et al.

Source: PLoS Medicine. 7/31/2025, Vol. 22 Issue 7, p1-17. 17p.

Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer.

Authors: Eisses, Bertha Angus, Lindsay Kuip, Evelien J. M. et al.

Source: Diagnostics (2075-4418). Apr2026, Vol. 16 Issue 8, p1197. 11p.

Germline BRCA1/2 Mutations in a Large Clinic-Based Cohort of Patients with Metastatic Breast Cancer in France.

Authors: Meynard, Guillaume Pereira, Victor Paget-Bailly, Sophie et al.

Source: Cancers. Mar2026, Vol. 18 Issue 5, p851. 12p.

Uptake Patterns of [ 18 F]Fluoroestradiol PET/MRI in Benign Breast Lesions and Molecular Breast Cancer Subtypes.

Authors: Spiegel, Thomas Rasul, Sazan Pötsch, Nina et al.

Source: Cancers. Feb2026, Vol. 18 Issue 4, p696. 14p.

Baduanjin exercise for menopausal symptoms in breast cancer patients on aromatase inhibitors: a randomized controlled pilot study.

Authors: Hou, Xiaohui Lan, Hao Cai, Li et al.

Source: Translational Exercise Biomedicine. Mar2026, Vol. 3 Issue 1, p13-23.

Accelerated Partial Breast Irradiation Delivered with Helical Tomotherapy: Dosimetry and Volumetric Predictors of Ipsilateral Breast Dose.

Authors: Chuang, Eva Yu-Hsuan Hsieh, Chen-Hsi Shueng, Pei-Wei et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2122. 13p.

Efficacy of AC‐T Versus TAC Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer: A Retrospective Analysis.

Authors: Mirzania, Mehrzad Anari, Fatemeh Emami, Seyed Amir Hossein et al.

Source: International Journal of Breast Cancer. 6/19/2026, Vol. 2026, p1-9. 9p.

Circulating Free miRNAs as Liquid Biopsy Biomarkers for Early Detection of Breast Cancer in Peruvian Women.

Authors: Arenas Machaca, Diana J. Martín de Bernardo, Álvaro Desposorio-Vicente, Daniel Alejandro et al.

Source: Cancers. Jun2026, Vol. 18 Issue 12, p1883. 18p.

Indocyanine Green as a Single Tracer for Axillary Staging in Breast Cancer: A Retrospective Single-Centre Cohort Study.

Authors: Ivanov, Valentin Khalid, Usman Dimov, Rosen et al.

Source: Cancers. May2026, Vol. 18 Issue 10, p1630. 16p.

An Initial Survey of Targeted Anticancer Drug Residues in Municipal Wastewater of Bangkok, Thailand.

Authors: Saengtienchai, Aksorn Yohannes, Yared Beyene Sreebun, Somkiat et al.

Source: Environments (2076-3298). May2026, Vol. 13 Issue 5, p246. 12p.

Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a.

Authors: Soran, Atilla Göktepe, Berk Demirors, Berkay et al.

Source: Current Oncology. Oct2025, Vol. 32 Issue 10, p556. 14p.

Complete response in a patient with metastatic metaplastic breast cancer treated with immune checkpoint inhibitor and chemotherapy: A case report and a review of the literature.

Authors: Chen, Jinghua Liu, Jie Li, Yixuan et al.

Source: Journal of Cancer Research & Therapeutics. Sep2025, Vol. 21 Issue 4, p955-959. 5p.